Related Experiment Video
Updated: Jul 6, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Projecting future drug expenditures--1995
Summary
Accurate drug expenditure projections require analyzing inflation trends, pharmacoeconomic research, new drug introductions, and healthcare delivery changes. Understanding these factors improves budget forecasting in the pharmaceutical market.
Area of Science:
- Health Economics
- Pharmaceutical Policy
- Drug Utilization Research
Background:
- Drug price inflation has decreased significantly due to managed care growth and fear of government price controls.
- Pharmaceutical industry analysts project modest price increases (2-5%) in the near future.
- Pharmacoeconomic research is gaining importance, necessitating critical evaluation by pharmacists.
Purpose of the Study:
- To discuss the use of various factors in projecting drug expenditures.
- To highlight the evolving landscape of healthcare delivery and its impact on drug spending.
- To emphasize the need for comprehensive analysis in drug budget forecasting.
Main Methods:
- Review of inflation data and market trends.
- Analysis of pharmacoeconomic research methodologies.
- Examination of new drug entity approvals and unlabeled drug uses.
- Assessment of practice-site-specific drug-use patterns and legislative impacts.
- Evaluation of shifts in healthcare delivery structures.
Main Results:
- Drug price inflation has declined from 6.9% (1991) to 2.2% (1994).
- Projected pharmaceutical price increases are estimated between 2-5% over the next 12-24 months.
- Healthcare delivery is shifting control of drug utilization from prescribers to large purchasers.
Conclusions:
- Accurate drug expenditure projections depend on a multi-faceted approach.
- Key factors include inflation, pharmacoeconomics, new drug pipelines, utilization patterns, legislation, and healthcare structure.
- Pharmacists must adapt to critically evaluate research and evolving market dynamics.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:11Drug Distribution: Overview
Drug distribution within the body is a dynamic process involving the movement of a drug in two directions across various compartments: from the bloodstream into tissues (tissue uptake) and from tissues back into the bloodstream (tissue release or redistribution). This process is passive and primarily driven by two variables: the concentration gradient between the bloodstream and the extravascular tissues and the drug's ability to cross the cell membrane.
Initially, the free drug in the...
Initially, the free drug in the...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).